SC
Srikanth Chiluka
About Srikanth Chiluka
Data last updated:
Srikanth Chiluka is a Director at Systomed Pharmaceuticals Private Limited (since 2021). The company operates in Trading. Systomed Pharmaceuticals Private Limited reported revenue of ₹17.1 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 22 Mar 2021 | 2021 | ₹17.1 Lakh (FY 2023) | Active |
Board colleagues of Srikanth Chiluka
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anumandla Divya Sri | 09117291 | Systomed Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Srikanth Chiluka
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Srikanth Chiluka
Srikanth Chiluka currently holds 1 directorship: Systomed Pharmaceuticals Private Limited (Director, since 22 Mar 2021, revenue ₹17.1 Lakh (FY 2023)).
Srikanth Chiluka was first appointed on 22 Mar 2021 as Director at Systomed Pharmaceuticals Private Limited.
The current boards of Srikanth Chiluka's companies include Anumandla Divya Sri (Systomed Pharmaceuticals Private Limited).